Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs63751011
rs63751011
T 0.700 CausalMutation CLINVAR [18F]AV-1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation. 28097206

2016

dbSNP: rs63750756
rs63750756
0.900 GeneticVariation BEFREE [<sup>11</sup> C]PBB3-PET can capture four-repeat tau pathologies characteristic of N279K mutant frontotemporal dementia and parkinsonism linked to chromosome 17/MAPT. 30773680

2019

dbSNP: rs63750756
rs63750756
0.900 GeneticVariation BEFREE We utilized CRISPR/Cas9 genome editing in human induced pluripotent stem (iPS) cell-derived neural progenitor cells (NPCs) to repair the FTD-associated N279K MAPT mutation. 28256506

2017

dbSNP: rs4878104
rs4878104
0.010 GeneticVariation BEFREE We showed a positive association between rs4878104 and FTD, s</span>uggesting a possible implication of the DAPK1 genetic variant in the susceptibility to FTD. 22785394

2012

dbSNP: rs1417373701
rs1417373701
0.010 GeneticVariation BEFREE We reported a Chinese FTD patient carrying TBK1 p.Ile334Thr variant detected by target sequencing and Sanger sequencing. 30672142

2019

dbSNP: rs767076633
rs767076633
0.010 GeneticVariation BEFREE We reported a Chinese FTD patient carrying TBK1 p.Ile334Thr variant detected by target sequencing and Sanger sequencing. 30672142

2019

dbSNP: rs773403329
rs773403329
0.010 GeneticVariation BEFREE We reported a Chinese FTD patient carrying TBK1 p.Ile334Thr variant detected by target sequencing and Sanger sequencing. 30672142

2019

dbSNP: rs63750711
rs63750711
0.810 GeneticVariation BEFREE We report on a 55-year old woman with frontotemporal dementia and a family history of FTDP-17 in whom we found a novel E12 (Glu342Val) tau gene mutation, prominent frontotemporal neuron loss, intracytoplasmic tau aggregates, paired helical tau filaments, increased 4R tau messenger RNA, increased 4R tau without E2 or E3 inserts, decreased 4R tau with these inserts, and a 4R:3R tau ratio greater than 1 in gray and white matter. 11117541

2000

dbSNP: rs63750711
rs63750711
0.810 GeneticVariation UNIPROT We report on a 55-year old woman with frontotemporal dementia and a family history of FTDP-17 in whom we found a novel E12 (Glu342Val) tau gene mutation, prominent frontotemporal neuron loss, intracytoplasmic tau aggregates, paired helical tau filaments, increased 4R tau messenger RNA, increased 4R tau without E2 or E3 inserts, decreased 4R tau with these inserts, and a 4R:3R tau ratio greater than 1 in gray and white matter. 11117541

2000

dbSNP: rs63750349
rs63750349
0.830 GeneticVariation BEFREE We report here on the clinical, neuroimaging, cerebral spinal fluid biomarker, genetic, biochemical and postmortem neuropathological analyses of a case of familial FTD with a Leu266Val MAPT mutation which results in a very early age of onset and a rapid course of disease. 17072625

2007

dbSNP: rs760049824
rs760049824
0.010 GeneticVariation BEFREE We report a novel exon 12 mutation in MAPT (S356T), in a family with an exceptionally early age at onset (27 and 29 years), causing familial behavioural variant frontotemporal dementia. 20708332

2010

dbSNP: rs63751165
rs63751165
0.830 GeneticVariation BEFREE We report a Japanese family with early onset hereditary frontotemporal dementia and a novel missense mutation (Ser305Asn) in the tau gene. 10208578

1999

dbSNP: rs72824905
rs72824905
0.010 GeneticVariation BEFREE We replicated the association of rs72824905-G with reduced AD risk and we found an association with reduced risk of dementia with Lewy bodies (DLB) and frontotemporal dementia (FTD). 31131421

2019

dbSNP: rs63750756
rs63750756
0.900 GeneticVariation BEFREE We investigated the underlying disease mechanism associated with the N279K tau mutation using PPND/FTDP-17 patient-derived induced pluripotent stem cells (iPSCs) and autopsy brains. 26373282

2015

dbSNP: rs1038579230
rs1038579230
VCP
0.010 GeneticVariation BEFREE We identified a known mutation of MAPT (p.Pro301Leu, c.902C>T) in four patients from an autosomal dominant FTD family with behavioral variant FTD (bvFTD) and progressive nonfluent aphasia (PNFA) phenotypes, and a novel mutation in MAPT (p.Leu48Val, c.142 G>C) in a sporadic progressive supranuclear palsy patient. 27439681

2016

dbSNP: rs762046989
rs762046989
0.010 GeneticVariation BEFREE We identified a known mutation of MAPT (p.Pro301Leu, c.902C>T) in four patients from an autosomal dominant FTD family with behavioral variant FTD (bvFTD) and progressive nonfluent aphasia (PNFA) phenotypes, and a novel mutation in MAPT (p.Leu48Val, c.142 G>C) in a sporadic progressive supranuclear palsy patient. 27439681

2016

dbSNP: rs63751273
rs63751273
0.900 GeneticVariation BEFREE We identified a known mutation of MAPT (p.Pro301Leu, c.902C>T) in four patients from an autosomal dominant FTD family with behavioral variant FTD (bvFTD) and progressive nonfluent aphasia (PNFA) phenotypes, and a novel mutation in MAPT (p.Leu48Val, c.142 G>C) in a sporadic progressive supranuclear palsy patient. 27439681

2016

dbSNP: rs1026683055
rs1026683055
GRN
0.010 GeneticVariation BEFREE We identified a known mutation of MAPT (p.Pro301Leu, c.902C>T) in four patients from an autosomal dominant FTD family with behavioral variant FTD (bvFTD) and progressive nonfluent aphasia (PNFA) phenotypes, and a novel mutation in MAPT (p.Leu48Val, c.142 G>C) in a sporadic progressive supranuclear palsy patient. 27439681

2016

dbSNP: rs762104961
rs762104961
0.010 GeneticVariation BEFREE We identified a known mutation of MAPT (p.Pro301Leu, c.902C>T) in four patients from an autosomal dominant FTD family with behavioral variant FTD (bvFTD) and progressive nonfluent aphasia (PNFA) phenotypes, and a novel mutation in MAPT (p.Leu48Val, c.142 G>C) in a sporadic progressive supranuclear palsy patient. 27439681

2016

dbSNP: rs63751273
rs63751273
T 0.900 CausalMutation CLINVAR We identified a known mutation of MAPT (p.Pro301Leu, c.902C>T) in four patients from an autosomal dominant FTD family with behavioral variant FTD (bvFTD) and progressive nonfluent aphasia (PNFA) phenotypes, and a novel mutation in MAPT (p.Leu48Val, c.142 G>C) in a sporadic progressive supranuclear palsy patient. 27439681

2016

dbSNP: rs63751273
rs63751273
0.900 GeneticVariation BEFREE We identified 2 missense mutations in exon 10: N279K and P301L in 2 Japanese patients with familial FTD. 11598310

2001

dbSNP: rs758576072
rs758576072
0.010 GeneticVariation BEFREE We have used a combined structural and cell biological approach to study if two frontotemporal dementia (FTD)-associated pathologic mutations, V337M and N279K, affect the aggregation, conformation and cellular internalization of the tau four-repeat domain (K18) fragment. 31338022

2019

dbSNP: rs377163259
rs377163259
0.010 GeneticVariation BEFREE We have used a combined structural and cell biological approach to study if two frontotemporal dementia (FTD)-associated pathologic mutations, V337M and N279K, affect the aggregation, conformation and cellular internalization of the tau four-repeat domain (K18) fragment. 31338022

2019

dbSNP: rs63750424
rs63750424
0.800 GeneticVariation BEFREE We have studied biochemical and structural parameters of several missense and deletion mutants of tau protein (G272V, N279K, DeltaK280, P301L, V337M, R406W) found in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). 10995239

2000

dbSNP: rs63751438
rs63751438
0.900 GeneticVariation BEFREE We have previously recapitulated aspects of human FTD in mouse models by overexpressing mutant human tau in CNS neurons, including a P301S tau variant in TAU58/2 mice, characterized by early-onset and progressive behavioral deficits and FTD-like neuropathology. 31366728

2019